+ All Categories
Home > Documents > In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Date post: 03-Feb-2017
Category:
Upload: dinhdung
View: 216 times
Download: 2 times
Share this document with a friend
22
In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs Renli Ma Jane Entwistle and John R Dean Renli Ma , Jane Entwistle and John R. Dean Biomolecular and Biomedical Research Centre School of Applied Sciences School of Applied Sciences, Northumbria University, UK
Transcript
Page 1: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

In-Vitro BioaccessibilityIn Vitro Bioaccessibility Studies of POPs

Renli Ma Jane Entwistle and John R DeanRenli Ma, Jane Entwistle and John R. Dean

Biomolecular and Biomedical Research CentreSchool of Applied SciencesSchool of Applied Sciences,Northumbria University, UK

Page 2: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

P i t t O i P ll t t St diPersistent Organic Pollutants Studies- Risk Assessment

Page 3: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Bi ibilitBioaccessibility

• Approaches to simulate the consequences to humans of consuming contaminated gmaterials.– Estimated using simulated in-vitroEstimated using simulated in vitro

gastro-intestinal extraction (also known as the physiologically-based extractionas the physiologically-based extraction test or PBET).POP i l t d il– POPs in plants and soils

Page 4: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs
Page 5: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Physiology of human contaminant uptake

Mouth 10 s to 2 mins

Stomach 8 mins to 3 hours

Duodenum30 mins to 45 mins Duodenum

Jejunum Small intestines

30 mins to 45 mins

1.5 to 2 hours

Ileum4 to 7 hours

Page 6: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Physiology of the human digestive tract

• Mouth: intake of material followed by mastication (often excluded from PBETmastication (often excluded from PBET process).

• Gastric: mechanical and chemical breakdown of material in the stomach.

• Intestines: Absorption of components through membranethrough membrane.

Page 7: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

PBET: Important variablesp• Temperature (37 °C)• Solid to solution ratio (1:2 through to 1:150 w/v)• Solid to solution ratio (1:2 through to 1:150 w/v)• Mixing - how? orbital or horizontal; stirred; inert

atmosphereatmosphere• Incubation time (1 to 5 hours)

Additi f f d t i l ilk d• Addition of food materials e.g. milk powder• Enzymes used (gastric juice – pepsin 1.25 to 10

/ l d h d hl i id t H f 1 1 t 4mg/ml and hydrochloric acid at pH from 1.1 to 4; intestinal juice – pancreatin and bile salt, pH 5-8)S ti t h i ( t if ti /filt ti )• Separation technique (centrifugation/filtration)

• Extraction: SPE or LLE• Analytical Technique: GC-MS

Page 8: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

A current applicationA current application

• Pesticides, phenols and BNAs in soil CRMs

Methodology:1 E tract soil CRMs b PFE and So hlet e traction to1. Extract soil CRMs by PFE and Soxhlet extraction to

obtain baseline data on total POP content.

2 E bli h LLE f i /i i l fl id2. Establish LLE recovery from gastric/intestinal fluids

3. Subject soil samples to PBET.

4. Extract gastric and intestinal fluid phases with LLE; Extract residual fraction with PFE. Produce results.

Page 9: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

What is PFE?Load sample into cell + drying agent+ copper?

Fill cell with solvent~0.5 min

Heat (40-200°C) and pressurize (1000-3000psi)

Cell ~5 minCell 5 min

Hold sample at pressureand temperature

Static extraction (5-10 min)

Pump clean solvent into cell (0 min) ll l0.6 x cell volume

Purge with N2 (1-2 min)

Analysis

Page 10: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

1. Extract soil CRMs by PFE and Soxhlet extraction to obtain baseline data on total POP content.

25

30

/kg)

Pesticides in CRM 805-050

5

10

15

20

once

ntra

tion

(mg/

PFESoxhletcertificate

0

linda

ne

endo

sulph

an I

endri

n

p,p'-D

DE

p,p'-D

DD

endo

sulph

an II

co

60708090

mg/

kg)

BNAs in CRM 107-100

Phenols in CRM 401-225 0102030405060

conc

entra

tion

(m PFESoxhletcertificate

3000

3500

4000

/kg)

Phenols in CRM 401-225 0

hexa

chlor

oethan

e

acen

apthen

e

dibenz

ofuran

fluore

nehe

xach

loroeth

ane

1000

1500

2000

2500

conc

entr

atio

n (m

g/

PFESoxhletcertificate

0

500

cresol 2,4,6-trichlorophenol PCP

c

Page 11: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

2 Establish LLE recovery from gastric/intestinal fluids2. Establish LLE recovery from gastric/intestinal fluids

PBET requires some form of liquid – liquid extraction prior to chromatographic analysis.extraction prior to chromatographic analysis.

Average LLE recoveries (using 3 x 10 mL DCM) f t i d i t ti l fl idDCM) from gastric and intestinal fluids was 88.9 ± 3.3 % (n = 27).

Page 12: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

3. Subject soil samples to PBET.

S lSample(5 g soil)

G t i J iGastric Juice[1% w/v pepsin in saline at pH 1.8 (with HCl), shake at

37 °C for 3 hours]37 C for 3 hours]

Intestinal Juice[3% w/v pancreatin and 1% w/v amylase in saline and 0.15% w/v bile

l i li H 7 h k 37 C f 3 h ]salts in saline at pH 7, shake at 37°C for 3 hours]

Page 13: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Pesticides % Recoveries from a soil CRM 805-050 and analysis by LLE/PFE-GC-MS

pesticide Gastric Intestinal ResidualLindane 0 5.3 94.70 5.3 94.7

Endosulphan I 0 6.6 93.4

Endrin 0 6.4 93.6

DDE 0 8.0 92.0

DDD 0 7 9 92 1DDD 0 7.9 92.1

Endosulphan II 0 12.8 87.2

Page 14: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Phenols % Recoveries from a soil CRMPhenols % Recoveries from a soil CRM 401-225 and analysis by LLE/PFE-GC-MS

Phenol Gastric Intestinal Residual

Cresol 2.0 4.1 93.9

TCP 1.6 4.6 93.8

PCP 1.9 5.4 92.7

Page 15: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

BNAs % Recoveries from a soil CRM 107-BNAs % Recoveries from a soil CRM 107100 and analysis by LLE/PFE-GC-MS

BNA Gastric Intestinal ResidualHexachlorethane 4.0 9.2 86.8

Acenaphthene 2 5 7 8 89 7Acenaphthene 2.5 7.8 89.7

Dibenzofuran 1 4 6 6 92 01.4 6.6 92.0

Fluorene 3.6 7.4 89.0

Hexachlorobenzene 2.0 12.7 85.3

Page 16: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

ConclusionsConclusions• Simulated in-vitro gastro-intestinalSimulated in vitro gastro intestinal

extraction (PBET) is a useful approach to estimate the bioaccessibility of POPsto estimate the bioaccessibility of POPs.

• Majority of POPs present are not bioaccessible (<20%).

• Differences noted between pesticidesDifferences noted between pesticides and phenols/BNAs in gastric fluid.I i l fl id h i• Intestinal fluid the most important.

Page 17: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Future issues (1)( )• Does PBET adequately model the risk to q y

human health?– Are POPs much more complicated than metalsAre POPs much more complicated than metals

to apply to a PBET approach?– Is the current PBET methodology for metalsIs the current PBET methodology for metals

sophisticated enough for POPs?– What needs to be done to improve theWhat needs to be done to improve the

approach?• What about potential POPs – gastric /• What about potential POPs – gastric /

intestinal fluid interactions? (GC-MS is often used in SIM mode)used in SIM mode).

Page 18: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Future issues (2)• No consideration given to the potential for

utu e ssues ( )g p

microbial degradation of POPs in the intestinal phase.p

• Further work is needed to ‘standardise’ on the approaches possible to perform in-vitrothe approaches possible to perform in vitro gastro-intestinal extraction (PBET).How can we obtain reliable data to be able• How can we obtain reliable data to be able to transfer methodology from lab to lab

ith t d fi d t l?without a defined protocol?• Development of PBET CRMs for POPs /

PAHs.

Page 19: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Future issues (3)• Influence of soil parameters (e.g. soil

utu e ssues (3)( g

organic matter, clay content etc.) on bioaccessibility not yet investigated.y y g

• Evaluation of most effective extraction methodology required (LLE versus SPE)methodology required (LLE versus SPE).

• Could the process be modelled using physical constants e g Kow etcphysical constants e.g. Kow etc.

Page 20: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Sponsors of PBET workSponsors of PBET work

• EPSRC Industrial case award in collaboration with LGC limited, London, with support from the Department of Trade and Industry under the National MeasurementTrade and Industry under the National Measurement System Valid Analytical Measurement (VAM) Programme. g

• The Royal Thai Government • Northumbria Universityo u b a U e s y• British Geological Survey

Page 21: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Selected Publications• "Methods for environmental trace analysis", J.R. Dean, John Wiley and Sons, (2003)

• “Recent developments to assess the bioavailability of persistent organic pollutants in the environment” J R Dean• Recent developments to assess the bioavailability of persistent organic pollutants in the environment , J.R. Dean and W.C. Scott, Trends in Analytical Chemistry, 23, 609-618 (2004).

• “An assessment of the bioavailability of persistent organic pollutants from contaminated soil”, W.C. Scott and J.R. Dean, Journal of Environmental Monitoring, 7, 710-715 (2005).Dean, Journal of Environmental Monitoring, 7, 710 715 (2005).

• “Uptake and bioavailability of endosulfan by lettuce grown in contaminated soil”, F.A. Esteve-Turrillas, W.C. Scott, A. Pastor and J.R. Dean, Journal of Environmental Monitoring, 7, 1093- 1098 (2005).

• “Uptake of heavy metals by vegetable plants grown on contaminated soil and their bioavailability in the human gastro-intestinal tract”, M. Intawongse and J.R. Dean, Food Additives and Contaminants, 23(1), 36-48 (2006).

• “In-vitro testing for assessing oral bioaccessibility of trace metals in soil and food samples”, M. Intawongse and g g y p , gJR Dean, Trends in Analytical Chemistry, 25(9), 876-886 (2006)

• “Bioavailability, bioaccessibility and mobility of environmental contaminants”, JR Dean, John Wiley and Sons Ltd., Chichester.

• “Approaches to assess the oral bioaccessibility of persistent organic pollutants: A critical review “, JR Dean and R. Ma, Chemosphere, 68, 1399-1407 (2007)

• “Use of the physiologically-based extraction test to assess the oral bioaccessibility of metals in vegetable plants grown in contaminated soil”, M. Intawongse and JR Dean, Environmental Pollution, in press.

Page 22: In-Vitro Bioaccessibility In Vitro Bioaccessibility Studies of POPs

Funding Opportunity - Leverhulme TrustFunding Opportunity Leverhulme Trust

• Calling for expressions of interest in theCalling for expressions of interest in the development and support of international networks for academic collaborationnetworks for academic collaboration. – between one or more UK HEIs and two or

more overseas institutions. • The award will be up to £125k, and last forThe award will be up to £125k, and last for

up to three years. O tli li ti d b tl• Outline applications now and subsequently invited full applications by 21 March, 1 September and 1 December 2008.


Recommended